| AAPH | 2,2′-azo-bis-(2-methylpropionamidine) dihydrochloride |
| ABC | ATP binding cassette |
| ADR | Adriamycin, trade name of doxorubicin |
| BCRP | breast cancer resistance protein |
| BHA | butylated hydroxyanisole |
| BHT | butylhydroxytoluen |
| CAA | cellular antioxidant activity |
| COX-2 | cyclooxygenase-2 |
| DCFH-DA | 2′,7′-dichlorofluorescin diacetate |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| DMEM | Dulbecco’s Modified Eagle’s Medium - high glucose |
| EMEM | Eagle´s Minimum Essential Medium |
| FBS | fetal bovine serum |
| FCR | Folin–Ciocalteu reagent |
| FRAP | ferric reducing ability of plasma |
| HepG2 | human hepatocellular adenocarcinoma |
| HOC | human ovarian adenocarcinoma |
| HOC/ADR | human ovarian adenocarcinoma resistant to doxorubicin |
| IL-1 | Interleukin-1 |
| iNOS | inducible isoform of nitric oxide synthases |
| LPS | lipopolysaccharides |
| LOX | lipoxygenase |
| MDR | multidrug resistance |
| MEM | Essential Medium Eagle no phenol red |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| ORAC | oxygen radical absorption capacity |
| P-gp | P-glycoprotein |
| PBS | Phosphate-buffered saline |
| RAW 264.7 | mouse macrophages |
| RLU | relative luminescence units |
| THTT | thyroid hormone transmembrane transporters |
| TNF-α | tumor necrosis factor alpha |